【结 构 式】 |
【药物名称】Elesclomol, STA-4783 【化学名称】Propanedioic acid bis[2-methyl-2-(phenylthiocarbonyl)hydrazide] 【CA登记号】488832-69-5 【 分 子 式 】C19H20N4O2S2 【 分 子 量 】400.5199 |
【开发单位】Synta Pharmaceuticals Corp. (US); developed under a global collaboration with GlaxoSmithKline (GB, US). 【药理作用】Apoptosis Inducer, Inducer of Oxidative Stress, HSP70 Inducer, Oncolytic |
合成路线1
Elesclomol can be prepared as follows. The precursor thiobenzoic acid N-methylhydrazide (III) can be obtained by either treatment of carboxymethyl dithiobenzoate (I) with methylhydrazine under alkaline conditions or by reaction of phenylmagnesium bromide (II) with carbon disulfide, followed by treatment with methylhydrazine. Then, dimerization of thiohydrazide (III) with malonic acid in the presence of DCC/HOBt, or with malonyl dichloride or malonic acid diphenyl ester, provides the target malonohydrazide derivative (1, 2). Conversion of elesclomol to different salts (including sodium, potassium, lithium, calcium, magnesium, ethanolamine and choline salts) has also been reported (3). Scheme 1.
【1】 Chen, S., Sun, L., Ono, M., Koya, K., Xia, Z.-Q. (SBR Pharmaceuticals Corp.). Synthesis of taxol enhancers. US 2003069225, US 6825235, WO 03006429. |
【2】 Koya, K., Sun, L., Ono, M., Tatsuta, N., Wu, Y., Chen, S. (Synta Pharmaceuticals Corp.). Taxol enhancer compounds. EP 1406869, EP 1731148, JP 2004534848, US 2003119914, WO 03006430. |
【3】 Kostik, E., Vaghefi, F., Liang, G. et al. (Synta Pharmaceuticals Corp.). EP 1781604, WO 2006009940. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 65625 | 2-(Benzothioylthio)acetic acid; S-(Thiobenzoyl)thioglycolic acid; Dithiobenzoic acid carboxymethyl ester | 942-91-6 | C9H8O2S2 | 详情 | 详情 |
(II) | 17616 | bromo(phenyl)magnesium; Phenyl Magnesium Bromide | 100-58-3 | C6H5BrMg | 详情 | 详情 |
(III) | 65626 | N-Methyl-N-thiobenzoylhydrazine; Thiobenzoic acid 1-methylhydrazide | 21048-05-5 | C8H10N2S | 详情 | 详情 |